Progranulin haploinsufficiency disrupts cathepsin D function, resulting in lysosomal abnormalities and elevated TDP-43 levels in the mouse brain
Abstract
Introduction Frontotemporal dementia (FTD) is a leading cause of early-onset neurodegeneration, frequently linked to mutations in the GRN gene, which encodes the protein progranulin (PGRN). PGRN is known to play a crucial role in lysosomal function, and its deficiency contributes to FTD pathogenesis. Here, we examined the consequences of PGRN loss on lysosomal homeostasis, focusing on the lysosomal protease cathepsin D (CTSD) and TAR DNA-binding protein 43 (TDP-43) aggregation, hallmarks of FTD and related neurodegenerative diseases. Methods Using mouse models with homozygous and heterozygous GRN deletions and double knockouts for GRN and CTSD, we assessed lysosomal function, CTSD expression and activity, lysosomal-associated membrane protein (LAMP) levels and localization, TDP-43 aggregation, and survival. Results PGRN deficiency resulted in significant alterations in lysosomal function. Despite significantly elevated levels of mature and immature CTSD in PGRN-deficient mice, enzymatic activity was significantly reduced. PGRN deficiency also caused accumulation of lysosomal-associated membrane protein (LAMP) and perinuclear clustering of LAMP1-positive lysosomes, suggestive of disrupted lysosomal trafficking. Correspondingly, insoluble TDP-43 levels significantly increased, implicating lysosomal impairment in defective protein degradation and aggregation. Remarkably, double-knockout mice lacking both PGRN and CTSD exhibited significantly shortened lifespans, highlighting a potential functional interaction between these proteins in maintaining neuronal health and longevity. Discussion These findings underscore the importance of PGRN as a central regulator of lysosomal function and protein homeostasis. Together, the data provide mechanistic insight into PGRN-dependent lysosomal biology and identify pathways that may contribute to GRN-associated FTD and other neurodegenerative disorders.